Arca
Skip to content

TFPI: Tissue factor pathway inhibitor

A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.

Inhibits factor X (X(a)) directly and, in a Xa-dependent way, inhibits VIIa/tissue factor activity, presumably by forming a quaternary Xa/LACI/VIIa/TF complex.

  • Drugs that act on it: 4
  • With a US drug page: 1
  • Type: Protein

Drugs That Act on It

Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page
MarstacimabApprovedTissue factor pathway inhibitor inhibitorInhibitor—
Andexanet alfa—Tissue factor pathway inhibitor inhibitorInhibitorBoxed warning
BAY-1093884—Tissue factor pathway inhibitor inhibitorInhibitor—
Concizumab—Tissue factor pathway inhibitor inhibitorInhibitor—

Diseases Most Associated With It

Open Targets association score, 0 to 1; all associations
Neurodegenerative disease
0.36
Hemorrhagic disease
0.36
Alzheimer disease
0.32
Parkinson disease
0.32
Lysosomal storage disease
0.32

Drugs and mechanisms are from ChEMBL CHEMBL3713062 (CC BY-SA 3.0). Gene name, function (UniProt P10646, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.